Home   Contact Us   Sitemap
 



 Financial & IR Update  News Update  Annual Report 2015-16
 
Indoco's Net Revenues Up by 6.2% - 3QFY17
Unaudited Standalone Financial Results for the Quarter and Nine Months ended 31st December, 2016 - Q3 FY17
Management Discussion & Analysis for the Third Quarter FY17
 
Indoco Remedies acquires a manufacturing facility, Business Standard
Indoco acquires Manufacturing plant in Baddi
Drug formulation market grows 9.5% in July to Rs 9,125 crore, Business Standard
Drug formulation market grows 9.5% in July to Rs 9,125 cr, Times of India
more

Disclaimer